Iomeprol shortage — DE supply status & alternatives

Iomeprol

—

🇦🇺 AUST R 63955 · Bracco Pty Ltd

In supply · Australia

Imeron 300

In supply · 🇦🇺 Australia · short in🇩🇪 DE

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Iomeprol
Brand names	Imeron 300
Therapeutic category	Auto-created by Bundesinstitut für Arzneimittel und Medizinprodukte — Lieferengpässe scraper

Marketing-authorisation holders	Bracco Pty Ltd

Registrations on file	5

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 2 resolved events

◷

0–1 months

Historical pattern from resolved shortage records — not a prediction of this event.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

1 API manufacturer

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Very high concentration risk

Suzhou Ryway Biotech CO LTD

Country of manufacture not yet mapped · Source: FDA List of Drug Master Files

FDA-approved products 🇺🇸 Drugs@FDA

Approved applications

Generic (ANDA)

Brand (NDA/BLA)

Nov 2024

Latest approval

Shortage status by regulator official notices

🇩🇪

Germany

BfArM · 12d ago

High

🇬🇷

EOF · 1mo ago

Resolved

Verified timeline regulator events

🇬🇷 1 May 2026

Shortage resolved

🇬🇷 24 Apr 2026

Shortage resolved

🇩🇪 15 Apr 2026

high reported

Sources official regulators

🇩🇪

BfArM

verified 12d ago

verify ↗

🇬🇷

EOF

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders5 registrations · 1 MA holder

Product	Strength	Form	Market	MA holder	Status
Iomeron	30.62g	—	🇦🇺 AU	Bracco Pty Ltd	Active
Iomeron	61.24g	—	🇦🇺 AU	Bracco Pty Ltd	Active
Iomeron	35.72g	—	🇦🇺 AU	Bracco Pty Ltd	Active
Iomeron	71.44g	—	🇦🇺 AU	Bracco Pty Ltd	Active
Iomeron	142.88g	—	🇦🇺 AU	Bracco Pty Ltd	Active

Mederti Drug Report

Generated 3 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.